Chemomab Therapeutics Ltd. (CMMB)
NASDAQ: CMMB · Real-Time Price · USD
2.360
+0.090 (3.96%)
Jul 6, 2026, 1:11 PM EDT - Market open
Chemomab Therapeutics Market Cap
Chemomab Therapeutics has a market cap or net worth of $16.99 million as of July 6, 2026. Its market cap has decreased by -27.32% in one year.
Market Cap
16.99M
Enterprise Value
8.30M
1-Year Change
-27.32%
Ranking
Category
Stock Price
$2.36
Market Cap Chart
Since March 17, 2021, Chemomab Therapeutics's market cap has decreased from $631.18M to $16.99M, a decrease of -97.31%. That is a compound annual growth rate of -49.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 6, 2026 | 16.99M | 67.32% |
| Dec 31, 2025 | 10.16M | -70.24% |
| Dec 31, 2024 | 34.13M | 466.14% |
| Dec 29, 2023 | 6.03M | -83.65% |
| Dec 30, 2022 | 36.88M | -53.12% |
| Dec 31, 2021 | 78.67M | -87.54% |
| Mar 17, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Celularity | 17.94M |
| GT Biopharma | 17.01M |
| Quince Therapeutics | 16.85M |
| Moolec Science | 16.57M |
| Werewolf Therapeutics | 16.54M |
| Vyome Holdings | 16.14M |
| Tempest Therapeutics | 16.14M |
| Citius Pharmaceuticals | 15.77M |